SERPINE1 and cancer: Patients bearing tumors with high SERPINE1 staining intensity (3) had a shorter progression-free (PFS) (p = 0.022) and cancer-specific survival (CSS) (p = 0.040) than patients with tumors showing intermediate (2) or low (1) staining.